← Eichor
Condition: Retroperitoneal Liposarcoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Retroperitoneal Liposarcoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for Liposarcomas
Phase 1 · 1 location(s) · University of Washington · NCT06025747
Genomic Risk in Retroperitoneal Sarcoma
Phase N/A · 1 location(s) · Fox Chase Cancer Center · NCT06436846
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Phase 3 · 169 location(s) · European Organisation for Research and Treatment of Cancer - · NCT04031677
Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients
Phase N/A · 1 location(s) · Royal Marsden NHS Foundation Trust · NCT07432932
Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
Phase N/A · 13 location(s) · Australia and New Zealand Sarcoma Association · NCT07377747
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.